- Home
- COOT vs PULM Comparison
COOT vs PULM Comparison
Compare COOT & PULM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COOT
- PULM
- Stock Information
- Founded
- COOT 2020
- PULM 2003
- Country
- COOT Australia
- PULM United States
- Employees
- COOT N/A
- PULM N/A
- Industry
- COOT
- PULM Biotechnology: Pharmaceutical Preparations
- Sector
- COOT
- PULM Health Care
- Exchange
- COOT NYSE
- PULM Nasdaq
- Market Cap
- COOT 23.0M
- PULM 21.0M
- IPO Year
- COOT N/A
- PULM N/A
- Fundamental
- Price
- COOT $1.25
- PULM $8.92
- Analyst Decision
- COOT
- PULM
- Analyst Count
- COOT 0
- PULM 0
- Target Price
- COOT N/A
- PULM N/A
- AVG Volume (30 Days)
- COOT 14.6K
- PULM 36.8K
- Earning Date
- COOT 01-01-0001
- PULM 03-27-2025
- Dividend Yield
- COOT N/A
- PULM N/A
- EPS Growth
- COOT N/A
- PULM N/A
- EPS
- COOT N/A
- PULM N/A
- Revenue
- COOT $23,793,673.00
- PULM $10,005,000.00
- Revenue This Year
- COOT N/A
- PULM N/A
- Revenue Next Year
- COOT N/A
- PULM $1.00
- P/E Ratio
- COOT N/A
- PULM N/A
- Revenue Growth
- COOT 16.10
- PULM 47.05
- 52 Week Low
- COOT $0.61
- PULM $1.55
- 52 Week High
- COOT $10.00
- PULM $10.40
- Technical
- Relative Strength Index (RSI)
- COOT 46.64
- PULM 62.72
- Support Level
- COOT $1.22
- PULM $8.80
- Resistance Level
- COOT $1.57
- PULM $10.40
- Average True Range (ATR)
- COOT 0.14
- PULM 0.59
- MACD
- COOT -0.01
- PULM 0.15
- Stochastic Oscillator
- COOT 27.48
- PULM 56.21
About COOT AUSTRALIAN OILSEEDS HOLDINGS LTD
Australian Oilseeds Holdings Ltd through its subsidiaries, is focused on the manufacture and sale of chemical-free, non-GMO, sustainable edible oils and products derived from oilseeds. The company believes that transitioning from a fossil fuel economy to a renewable and chemical-free economy is the solution to many health problems the world is facing presently.
About PULM Pulmatrix Inc.
Pulmatrix Inc is a clinical-stage biotechnology company. The company is focused on the discovery and development of novel inhaled therapeutic products intended to prevent and treat respiratory diseases and infections with significant unmet medical needs. Pulmatrix designs and develops inhaled therapeutic products based on its proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. The iSPERSE powders are engineered to be small, dense particles with dispersibility and delivery to airways.